So first the “less good” news … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer | Tagged: OPKO, point of care, PSA, Sangia, test | 6 Comments »
-
-
-
-
-
-
- The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
A service of
Awards
Other PCI web sites
-
PCaI’s ASVSG
If you are on or thinking about active surveillance (AS) as a way to manage your low-risk prostate cancer, you may want to join Prostate Cancer International’s Active Surveillance Virtual Support Group.
CureTalks on PCa
Our most recent CureTalk on Prostate Cancer (on February 21 this year) features Eli Van Allen, MD, of the Broad Institute and the Dana-Farber Cancer Center, talking about the new “Metastatic Prostate Cancer Project” and how you can become part of the solution.
For access to the full list of CureTalks on Prostate Cancer, please click here.
Disclaimer
News and information provided on this site should not be used for diagnosing or treating any health problem or disease.
The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.
-
Hot Posts …
- And now … FDA approves second PARP inhibitor for selected men with mCRPC
- FDA approves first PARP inhibitor for selected men with mCRPC
- Prostate cancer and coronavirus (COVID-19)
- Sipuleucel-T in management of favorable-risk prostate cancer: the ProVent trial
- Axumin-based PET/CT scans and detection of recurrent prostate cancer
- More negative data for checkpoint inhibition in treatment of mCRPC
- Olaparib in treatment of men with mCRPC and selected HRR gene mutations
- Alas … PPV not good for PI-RADS at all
- Will the FDA approve an oral LHRH antagonist for treatment of prostate cancer?
- Focal therapy for localized prostate cancer: the “state of the art”
- Long-term adjuvant ADT improves results of brachy-boost therapy in unfavorable-risk prostate cancer patients
- Is Howard done with biopsies “forever”?
- Radiation therapy for prostate cancer in the time of COVID-19
- Cancer patient survey on diet, exercise, and weight management
- Jane Brody on prostate cancer in the NYT
… and Archives
Blog at WordPress.com. WP Designer.
